HS-SPME-GC-MS analysis of volatile and semi-volatile compounds from dried leaves of Mikania glomerata Sprengel |
Esmeraldo A. Cappelaro; Janete H. Yariwake*
Universidade de São Paulo, Instituto de Química de São Carlos, CP 780, 13560-970 São Carlos - SP, Brasil Recebido em 25/08/2014 *e-mail: janete@iqsc.usp.br This paper reports on the identification of volatile and semi-volatile compounds and a comparison of the chromatographic profiles obtained by Headspace Solid-Phase Microextraction/Gas Chromatography with Mass Spectrometry detection (HS-SPME-GC-MS) of dried leaves of Mikania glomerata Sprengel (Asteraceae), also known as 'guaco.' Three different types of commercial SPME fibers were tested: polydimethylsiloxane (PDMS), polydimethylsiloxane/divinylbenzene (PDMS/DVB) and polyacrylate (PA). Fifty-nine compounds were fully identified by HS-SPME-HRGC-MS, including coumarin, a marker for the quality control of guaco-based phytomedicines; most of the other identified compounds were mono- and sesquiterpenes. PA fibers performed better in the analysis of coumarin, while PDMS-DVB proved to be the best choice for a general and non-selective analysis of volatile and semi-volatile guaco-based compounds. The SPME method is faster and requires a smaller sample than conventional hydrodistillation of essential oils, providing a general overview of the volatile and semi-volatile compounds of M. glomerata. INTRODUCTION Mikania glomerata Sprengel (Asteraceae) is one of the Mikania species known in Brazil by the popular name "guaco," whose leaves serve as raw material for commercial phytopharmaceuticals (extracts and syrups) used as expectorants and bronchodilators. A review of the situation of herbal medicines registered in Brazil revealed that M. glomerata is the native plant species with the largest number of registered phytomedicines (14 products in March 2008).1 In 2012, Brazil's Ministry of Health included M. glomerata in the official list of drugs used by the country's National Health Service (SUS). This official list includes only herbal medicines that have proven effectiveness and are manufactured and registered with Brazil's National Health Surveillance Agency (ANVISA - Agência Nacional de Vigilância Sanitária).2 Data obtained from a comparative study of the anatomy and molecular biology of M. glomerata and M. laevigata Schultz Bip. ex Baker (another Mikania species also popularly known in Brazil as "guaco") suggest that these two species could be unified in terms of nomenclature, due to their similarity.3 Phytochemical, biological and pharmacological investigations of "guaco" were reviewed, and the main compounds reported are coumarin and terpenoids (monoterpenes, sesquiterpenes and diterpenes), among others.4 The GC-MS analysis of the essential oil (EO) obtained by the hydrodistillation of fresh M. glomerata leaves led to the identification of oxygenated sesquiterpenes (72.5% of the EO), sesquiterpene hydrocarbons (22.6%), monoterpene hydrocarbons (1.7%) and oxygenated monoterpenes (0.3%); and another report of an analysis of EO from M. glomerata leaves, flowers and seeds also indicated that sesquiterpenes are the major compounds (81.5% of the EO from fresh leaves).5 GC techniques have been employed for the quantitative analysis of coumarin and kaurenoic acid from M. glomerata leaves.6 However, the quantification of coumarin by HPLC-UV has been suggested as a procedure for the quality control of guaco phytomedicines based on hydroalcoholic extracts,7 and this analytical strategy has been applied in the development of guaco phytomedicines.8 Pharmacological studies of the antiallergic activity of ethanol extracts of M. glomerata leaves confirm the use of coumarin as one of the markers of this species.9 Moreover, coumarin as well as o-coumaric acid have been quantified by HPLC-UV in a comparative study of M. glomerata and M. laevigata, and these two compounds have been identified as partly responsible for the therapeutic activity of both guaco species.10 The first step in the production of standardized phytomedicines is to ensure the quality of herbal material used as raw material. Moreover, there is an increasing demand for the development of versatile and faster analytical methods suitable for routine quality control analysis on the scale required by the phytopharmaceutical industry. In this context, headspace solid-phase microextraction (HS-SPME) has proved to be a successful technique for studying the composition of the volatile fraction of a plant. A review by Bicchi and co-workers summarizes the evolution of vapor phase sampling of the volatile fraction of vegetable matrices, including HS-SPME applications. In their review, the authors also point out the confusion between the definitions of headspace (HS) and EO in the literature, although they recognize that HS and EO composition may sometimes be similar, in the case of plant matrices. Another review by Bicchi and co-workers, covering the field of aromatic and medicinal plants, discusses the advantages and limitations of HS-SPME as an alternative or a complement to EO analysis, and these authors also discussed further examples of the advantages and limitations of HS-SPME in the analysis of the EO of medicinal plants EO.11 A recent review of Jeleńa and co-workers, about analysis of food flavor volatile compounds, shows the leading position of SPME among the most popular microextraction methods of volatile compounds important for food quality, including vegetable foods such as fruits and vegetables, spices and herbs, among others.12 Despite the evolution and widespread acceptation of HS-sampling in the analysis of plant material, most of the official methods for plant drug analysis still do not consider SPME sampling for the quality control of medicinal plants. Therefore, within the scope of the proposition of faster analytical methods that are alternatives to the conventional procedures for the analysis of Brazilian phytomedicines, this study compares the HS-SPME-HRGC-MS analysis of volatile and semi-volatile compounds from dried Mikania glomerata leaves, using three different commercial fibers, and suggests HS-SPME as an alternative analytical approach that can be used as a complement in the quality control of M. glomerata phytomedicines, particularly in the analysis of herbal raw material.
EXPERIMENTAL Plant material Mikania glomerata leaves (Voucher UNESP BOTU 19813) were obtained from specimens grown in Ribeirão Preto, SP, Brazil. Plants were harvested in the morning, and the leaves were immediately separated from the other aerial parts and dried in the shade at room temperature (average temperature of 22 to 30 ºC) until they reached a constant weight. The leaves were separated and samples of 10 g each were stored separately in hermetically sealed plastic bags. These bags were opened immediately prior to HS-SPME sampling. HS-SPME sampling The SPME device and the fused silica fibers were purchased from Supelco (Bellafont, PA, USA). The following fibers were employed: 100 mm poly(dimethylsiloxane) (PDMS), 65 mm poly(dimethylsiloxane)-divinylbenzene (PDMS-DVB), 65 mm polyacrylate. All fibers were conditioned prior to use as recommended by manufacturer. The analytical conditions described for HS-SPME sampling were chosen after preliminary assays using different amounts of dried plant material, different extraction and desorption conditions (time, temperature, equilibrium time). Dried M. glomerata leaves samples were hand-cut with a scissor and powdered using a domestic blender and grounded, and only particles smaller than 50 mesh were utilized for the HS-SPME step. A sample of plant material (60 mg) was sealed in 2 mL vials and stored at -18 ºC for 2 h at least) before HS-SPME sampling. The SPME device was inserted into the sealed vial containing the plant sample and the fiber was exposed to the headspace (equilibration time 15 min and temperature 50 ºC; sampling time 120 min and temperature 50 ºC). After sampling, the SPME device was immediately inserted into the GC injector and the fiber was thermally desorbed for 15 min at 230 ºC. Gas chromatography - mass spectrometry analysis Analysis were carried out on an Agilent GC-6890 Plus system coupled to a 5973 MSD (Little Falls, DE, USA). For HS-SPME-HRGC-MS analysis, the injector was operated in the splitless mode at 230 ºC during 5 min and thereafter split (split ratio 1:10), and the chromatographic conditions were: column, HP-5 MS (25 m × 0.25 mm i.d., 0.3 mm film thickness; Agilent); temperature programme, from 40 ºC (held for 3 min) to 125 ºC (0 min) at 4 ºC min-1, then at 1.5 ºC min-1 to 140 ºC (4 min) and finally at 5 ºC min-1 to 250 ºC (5 min); carrier gas was He at flow rate of 1.0 mL min-1 in constant flow mode. Interface temperature was 280 ºC and the MS were obtained in the electron impact mode at 70 eV, scan mode, range m/z 35-350 at a rate of 2.36 scans s-1. Data were acquired in a PC system using software ChemStation G1701CA (Agilent). Compounds were identified by comparison of their linear retention indices, relative to C8-C25 n-alkanes, and their MS with those of authentic samples or components of reference essential oils.
RESULTS AND DISCUSSION Most of the compounds extracted by HS-SPME are mono- and sesquiterpenes, and 59 compounds were fully identified by HS-SPME-HRGC-MS (Table 1). Several peaks were not fully identified, but fragmentation data also furnished strong evidence about their partial structural information, which is also included in Table 1. Previous reports of the analysis of EO from M. glomerata are described in the literature,6 but the direct comparison of EO and HS-SPME is not strictly correct, since the fundamental principles of the two techniques differ completely, which influences the quantitative and qualitative chemical composition of EO and headspace.11 Taking these considerations into account, however, HS-SPME-HRGC-MS analysis led to the identification of several volatile compounds from M. glomerata not previously reported.5
A comparison of the chromatographic profiles obtained by HS-SPME-HRGC-MS (Figure 1) indicates that the main difference between the three HS-SPME profiles was the extraction efficiency of different fibers under the same conditions, since the number of extracted compounds is almost the same. Considering the sum of the areas of the detected peaks in TIC (Σ A) as a criterion to measure extraction efficiency, PDMS-DVB fiber showed the highest efficiency (Σ APDMS-DVB = 6.10 × 109, s.d. ±5.2%), i.e., almost twice that of PA (Σ APA = 3.65 × 109, s.d. ±4.9%) and PDMS (Σ APDMS = 3.31 × 109, s.d. ±3.5%) fibers. Coumarin was extracted with greater efficiency by PA fiber (28.37% of Σ APA, compared to 18.11% of Σ APDMS-DVB and 7.27% of Σ APDMS).
Figure 1. TIC-HRGC-MS profiles of volatile and semi-volatile compounds found by HS-SPME from Mikania glomerata dried leaves, using different SPME fibers. For identification of the peaks, see Table 1. PA: polyacrilate; DVB/PDMS: divinylbenzene / polydimethylsiloxane; PDMS: polydimethylsiloxane
HS-SPME-HRGC-MS showed a good performance, considering the result achieved in the extraction of coumarin (a chemical marker of M. glomerata). Moreover, the SPME procedure offers the advantages of requiring smaller samples and shorter time of analysis than the HRGC-FID and HPLC-UV methods previously reported for M. glomerata.6 HS-SPME-HRGC-MS is also faster than the conventional hydrodistillation procedure for EO analysis (around 4 hours only for hydrodistillation step), and the latter procedure has the additional disadvantages of requiring hundreds of grams of plant material and of potentially generating artifacts due to the long exposure of plant material to water steam. Hence, the SPME method may be a valuable tool for screening and characterizing the chemical composition of volatile and semi-volatile compounds of M. glomerata in studies requiring a large number of plant samples and/or when a limited amount of plant material is available for several samplings, such as dynamic plant biological processes (including metabolomic studies), micropropagation or cloning for cultivation purposes, etc. In addition, it is easier to automate the HS-SPME approach using online systems that combine sample preparation and GC analysis.
CONCLUSIONS The chemical analysis of any phytomedicine must be standardized, and this perforce includes the volatile fraction. Considering that quality assurance in routine processes such as health surveillance, or during the industrial production of phytomedicines, requires reproducible and fast methods, and also in view of the increasing interest in "environmentally friendly" techniques such as SPME to replace some procedures adopted in Pharmacopoeias that are difficult to adapt to modern and automated analytical methods, the results presented here suggest HS-SPME-HGRC-MS as a potential analytical tool for the analysis of volatile and semi-volatile compounds of M. glomerata.
ACKNOWLEDGEMENTS This work was supported by FAPESP and CNPq (Brazil). The authors wish to thank Mr. A. Menezes (UNAERP, Ribeirão Preto, SP, Brazil), that kindly provided plant material, and to Dr. B. Sgorbini, Prof. P. Rubiolo and Prof. C. Bicchi (Università degli Studi di Torino, Italia), for technical assistance and criticisms.
REFERENCES 1. Carvalho, A. C. B.; Balbino, E. E.; Maciel, A.; Perfeito, J. S.; Rev. Bras. Farmacogn. 2008, 18, 314. DOI: http://dx.doi.org/10.1590/S0102-695X2008000200028 2. Diário Oficial da União - Seção 1, nº 62, 29/03/2012. Portaria nº 533, 28/03/2012 and http://portal.saude.gov.br/portal/arquivos/pdf/anexos_rename_2012_pt_533_30_03_12.pdf 3. Bastos, C. L.; da Mata, C. S.; Maia, V. H.; Borges, R. A. X.; Franco, L. O.; Ferreira, P. C. G.; Tamaio, N.; J. Med. Plants Res. 2011, 18, 4579. 4. Napimoga, M. H.; Yatsuda, R.; J. Pharm. Pharmacol. 2010, 62, 809; Czelusniak, K. E.; Brocco, A.; Pereira, D. F.; Freitais, G. B. L.; Revista Brasileira de Plantas Medicinais 2012, 14, 400. PMID: 20636868 5. Limberg, R. P.; Aboy, A. L.; Bassani, V. L.; Moreno, P. R. H.; Ritter, M. R.; Henriques, A. T.; J. Essent. Oil Res. 2001, 13, 225; Rehder, V. L. G.; Sartoratto, A.; Rodrigues, M. V. N.; Revista Brasileira de Plantas Medicinais 2006, 8, 116. DOI: http://dx.doi.org/10.1080/10412905.2001.9699676 6. Vilegas, J. H. Y.; de Marchi, E.; Lanças, F. M.; Phytochem Anal. 1997, 8, 74; Vilegas, J. H. Y.; de Marchi, E.; Lanças, F. M.; Phytochem. Anal. 1997, 8, 266; Bueno, P. C. P.; Bastos, J. K.; Rev. Bras. Farmacogn. 2009, 19, 218. DOI: http://dx.doi.org/10.1002/(SICI)1099-1565(199703)8:2<74::AID-PCA332>3.0.CO;2-8 7. Celeghini, R. M. S.; Vilegas, J. H. Y.; Lanças, F. M.; J. Braz. Chem. Soc. 2001, 12, 706. 8. Rocha, L.; Lucio, E. M. A.; França, H. S.; Sharapin, N.; Rev. Bras. Farmacogn. 2008, 18, 744. DOI: http://dx.doi.org/10.1590/S0102-695X2008000500019 9. Fierro, I. M.; da Silva, A. C. B.; Lopes, C. da S.; de Moura, R. S.; Barja-Fidalgo, C.; J. Ethnopharm. 1999, 66, 19. DOI: http://dx.doi.org/10.1016/S0378-8741(98)00151-2 10. dos Santos, S. C.; Krueger, C. L.; Stell, A. A.; Kreuger, M. R.; Biavatti, M. W.; Wisniewski Jr., A; Planta Med. 2006, 72, 679. DOI: http://dx.doi.org/10.1055/s-2006-931577 PMID: 16755468 11. Bicchi, C.; Cordero, C.; Liberto, E.; Sgorbini, B.; Rubiolo, P.; J. Chromatogr. A 2008, 1184, 220; Belliardo, F.; Bicchi, C.; Cordero, C.; Liberto, E.; Rubiolo, P.; Sgorbini, B.; J. Cromatogr. Sci. 2006, 44, 416; Rubiolo, P.; Belliardo, F.; Cordero, C.; Liberto, E.; Sgorbini, B.; Bicchi, C.; Phytochem. Anal. 2006, 17, 217; Bicchi, C.; Cordero, C.; Liberto, E.; Sgorbini, B.; Rubiolo, P.; J. Chromatogr. A 2007, 1152, 138. DOI: http://dx.doi.org/10.1016/j.chroma.2007.06.019 PMID: 17624361 12. Jeleńa, H. H.; Majchera, M., Dziadasa, M.; Anal. Chim. Acta 2012, 738, 13. DOI: http://dx.doi.org/10.1016/j.aca.2012.06.006 |
On-line version ISSN 1678-7064 Printed version ISSN 0100-4042
Qu�mica Nova
Publica��es da Sociedade Brasileira de Qu�mica
Caixa Postal: 26037
05513-970 S�o Paulo - SP
Tel/Fax: +55.11.3032.2299/+55.11.3814.3602
Free access